Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women

Journal of Acquired Immune Deficiency Syndromes

Volumn 24, Issue 1, 2000, Pages 1-9

  Tscherning Casper, Charlotte ^a   Vödrös, Dalma ^a   Menu, Elisabeth ^b,c   Aperia, Kajsa ^d   Fredriksson, Robert ^a   Dolcini, Guillermina ^b   Chaouat, Gérard ^c   Barré Sinoussi, Françoise ^b   Albert, Jan ^d   Fenyö, Eva Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Bonzo; CCR5; Coreceptor usage; HIV 1 subtype A; HIV 1 transmission from mother to child; Multitropism

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2B; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ARTICLE; CAMEROON; CONTROLLED STUDY; DNA SEQUENCE; ENVELOPE GENE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 12944309897     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200005010-00001     Document Type: Article

References (42)

1. Lindgren S, Anzén B, Bohlin AB, Lidman K. HIV and child-bearing: clinical outcome and aspects of mother-to-infant transmission. AIDS 1991;5:1111-16.
2. Burns DN, Landesman S, Minkoff H, et al.The influence of pregnancy on HIV type 1 infection: antepartum and postpartum changes in HIV type 1 viral load. Am J Obstet Gynecol 1998;178: 355-9.
3. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor - functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
4. Simmons G, Wilkinson D, Reeves JD, et al. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dualtropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-60.
5. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second receptor use. Nature 1996;383:768.
6. Alkhatib G, Combadiere C, Broder CC, et al. CC CKRs - A RANTES, MIP-1-alpha, MIP-1-beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
7. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptor CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
8. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
9. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
10. Doranz BJ, Rucker J, Yi YJ, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
11. Karlsson A, Parsmyr K, Sandström E, Fenyö EM, Albert J. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J Clin Microbiol 1994; 32:364-70.
12. Koot M, Keet IPM, Vos AHV, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
13. Björndal Å, Deng HK, Jansson M, et al. Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71:7478-87.
14. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998;241:181-8.
15. Björndal Å, Sönnerborg A, Tscherning C, Albert J, Fenyö EM. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolate of Ethiopian AIDS-patients. AIDS Res Hum Retroviruses 1999;15:647-53.
16. WHO. WHO/CDC case definition for AIDS. Wkly Epidemiol Rec 1986;61:69-73.
17. Menu E, M'bopi Keou FX, Lagaye S, et al. Selection of maternal HIV-1 variants in human placenta. J Infect Dis 1998;179:68-73.
18. Menu E, Truong TX, Lafon ME, et al. HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res Hum Retroviruses 1996;12:629-33.
19. World Health Organization. WHO guidelines for standard HIV isolation procedures. Geneva, Switzerland: World Health Organization, 1993.
20. Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyö EM, Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol 1989;29:170-5.
21. Deng H, Unutmaz D, Kewal-Ramani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
22. Boucher CAB, Lange JMA, Miedema F, et al. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS 1992;6:1259-64.
23. Weber J, Fenyö EM, Nara P, et al. Neutralisation serotypes of HIV-1 field isolates are not predicted by genetic subtype. J Virol 1996;70:7827-32.
24. Roques P, Menu E, Narwa R, et al. An unusual HIV type-1 env sequence embedded in a mosaic virus from Cameroon: identification of a new env clade. AIDS Res Hum Retroviruses 1999;15: 1585-9.
25. Nkengasong JN, Janssens W, Heyndrix L, et al., Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994;8:1405-12.
26. Alkhatib G, Liao F, Berger EA, Farber JM. A new SIV coreceptor, STRL33. Nature 1997;388:238.
27. Endres MJ, Clapham PR, Marsch M, et al. CD4 independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996;87:745-56.
28. Zhang YJ, Dragic T, Cao Y, et al. Use of coreceptors other than CCR5 and CXCR4 by adult and pediatric isolates of HIV-1 is rare in vitro. J Virol 1998;72:9337-44.
29. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of trasmission. Lancet 1991;337:253-60.
30. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
31. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-42.
32. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585-8.
33. Roques P, Marce D, Courpotin C, et al. Correlation between HIV provirus burden and in utero transmission. AIDS 1993;7:S39-S43.
34. Fang G, Burger H, Grimson R, et al. Maternal plasma human immunodeficiency virus type 1 level: a determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92:12100-4.
35. Cao Y, Krogstad P, Korber BT, et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel project for the prevention of HIV transmission from mother to infant. Nat Med 1997;3:549-52.
36. Carr JK, Salminen MO, Albert J, et al. Full genome sequences of HIV type 1 subtypes G and A/G intersubtype recombinant. Virology 1998;247:22-31.
37. Carr JK, Laukkanen T, Salminen MO, et al. Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS 1999;13:1819-26.
38. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 1993;197:624-9.
39. Scarlatti G, Tresoldi E, Björndal Å, et al. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997;3:1259-65.
40. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
41. Kollman TR, Pettoello-Mantovani M, Katopolis NF, et al. Inhibition of acute in vivo HIV infection by human IL-10 treatment of SCID mice implanted with human fetal thymus and liver. Proc Nail Acad Sci USA 1996;93:3126-31.
42. Rübsamen-Waigmann H, von Briesen H, Holmes H, et al. Standard conditions of virus isolation reveal biological variability of HIV-1 in different regions of the world. AIDS Res Hum Retroviruses 1994;10:1401-8.